rs184215485

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002458.3(MUC5B):​c.9626G>A​(p.Arg3209Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0253 in 150,046 control chromosomes in the GnomAD database, including 68 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 68 hom., cov: 32)
Exomes 𝑓: 0.026 ( 907 hom. )
Failed GnomAD Quality Control

Consequence

MUC5B
NM_002458.3 missense

Scores

16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -5.15

Publications

4 publications found
Variant links:
Genes affected
MUC5B (HGNC:7516): (mucin 5B, oligomeric mucus/gel-forming) This gene encodes a member of the mucin family of proteins, which are highly glycosylated macromolecular components of mucus secretions. This family member is the major gel-forming mucin in mucus. It is a major contributor to the lubricating and viscoelastic properties of whole saliva, normal lung mucus and cervical mucus. This gene has been found to be up-regulated in some human diseases, including sinus mucosa of chronic rhinosinusitis (CRS), CRS with nasal polyposis, chronic obstructive pulmonary disease (COPD) and H. pylori-associated gastric disease, and it may be involved in the pathogenesis of these diseases. [provided by RefSeq, Jul 2010]
MUC5B-AS1 (HGNC:53936): (MUC5B antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0038914084).
BP6
Variant 11-1246506-G-A is Benign according to our data. Variant chr11-1246506-G-A is described in ClinVar as Benign. ClinVar VariationId is 403157.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0253 (3799/150046) while in subpopulation NFE AF = 0.033 (2222/67358). AF 95% confidence interval is 0.0318. There are 68 homozygotes in GnomAd4. There are 1875 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 68 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002458.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MUC5B
NM_002458.3
MANE Select
c.9626G>Ap.Arg3209Lys
missense
Exon 31 of 49NP_002449.2
MUC5B-AS1
NR_157183.1
n.56+3115C>T
intron
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MUC5B
ENST00000529681.5
TSL:5 MANE Select
c.9626G>Ap.Arg3209Lys
missense
Exon 31 of 49ENSP00000436812.1
MUC5B-AS1
ENST00000532061.2
TSL:5
n.56+3115C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0253
AC:
3800
AN:
149924
Hom.:
68
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0135
Gnomad AMI
AF:
0.00111
Gnomad AMR
AF:
0.00840
Gnomad ASJ
AF:
0.0288
Gnomad EAS
AF:
0.000403
Gnomad SAS
AF:
0.00772
Gnomad FIN
AF:
0.0688
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0330
Gnomad OTH
AF:
0.0223
GnomAD2 exomes
AF:
0.00978
AC:
2370
AN:
242354
AF XY:
0.00905
show subpopulations
Gnomad AFR exome
AF:
0.00726
Gnomad AMR exome
AF:
0.00283
Gnomad ASJ exome
AF:
0.00569
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0434
Gnomad NFE exome
AF:
0.00996
Gnomad OTH exome
AF:
0.0110
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0257
AC:
37187
AN:
1447650
Hom.:
907
Cov.:
126
AF XY:
0.0251
AC XY:
18060
AN XY:
720182
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0110
AC:
366
AN:
33310
American (AMR)
AF:
0.00480
AC:
214
AN:
44546
Ashkenazi Jewish (ASJ)
AF:
0.0233
AC:
602
AN:
25818
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00772
AC:
663
AN:
85914
European-Finnish (FIN)
AF:
0.0681
AC:
3589
AN:
52680
Middle Eastern (MID)
AF:
0.00452
AC:
26
AN:
5758
European-Non Finnish (NFE)
AF:
0.0276
AC:
30327
AN:
1100088
Other (OTH)
AF:
0.0234
AC:
1400
AN:
59838
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.346
Heterozygous variant carriers
0
1680
3360
5041
6721
8401
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1082
2164
3246
4328
5410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0253
AC:
3799
AN:
150046
Hom.:
68
Cov.:
32
AF XY:
0.0256
AC XY:
1875
AN XY:
73240
show subpopulations
African (AFR)
AF:
0.0134
AC:
548
AN:
40798
American (AMR)
AF:
0.00839
AC:
127
AN:
15142
Ashkenazi Jewish (ASJ)
AF:
0.0288
AC:
99
AN:
3436
East Asian (EAS)
AF:
0.000404
AC:
2
AN:
4948
South Asian (SAS)
AF:
0.00773
AC:
36
AN:
4660
European-Finnish (FIN)
AF:
0.0688
AC:
718
AN:
10438
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
280
European-Non Finnish (NFE)
AF:
0.0330
AC:
2222
AN:
67358
Other (OTH)
AF:
0.0221
AC:
46
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.441
Heterozygous variant carriers
0
159
318
476
635
794
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0303
Hom.:
18
Bravo
AF:
0.0204
ExAC
AF:
0.0228
AC:
2770

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.0020
DANN
Benign
0.36
DEOGEN2
Benign
0.016
T
Eigen
Benign
-2.1
Eigen_PC
Benign
-2.1
FATHMM_MKL
Benign
0.00030
N
LIST_S2
Benign
0.31
T
MetaRNN
Benign
0.0039
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-1.4
N
PhyloP100
-5.2
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-0.23
N
REVEL
Benign
0.0030
Sift
Benign
0.93
T
Vest4
0.0030
ClinPred
0.0047
T
GERP RS
-1.8
Varity_R
0.040
gMVP
0.17
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs184215485; hg19: chr11-1267736; COSMIC: COSV106116135; API